FR2125435A1 - Antiarhythmic organomercuric cpds - esp fluorescein derivs - Google Patents

Antiarhythmic organomercuric cpds - esp fluorescein derivs

Info

Publication number
FR2125435A1
FR2125435A1 FR7204789A FR7204789A FR2125435A1 FR 2125435 A1 FR2125435 A1 FR 2125435A1 FR 7204789 A FR7204789 A FR 7204789A FR 7204789 A FR7204789 A FR 7204789A FR 2125435 A1 FR2125435 A1 FR 2125435A1
Authority
FR
France
Prior art keywords
derivs
organomercuric
fluorescein
antiarhythmic
cpds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7204789A
Other languages
English (en)
French (fr)
Other versions
FR2125435B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Czech Academy of Sciences CAS
Original Assignee
Czech Academy of Sciences CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Czech Academy of Sciences CAS filed Critical Czech Academy of Sciences CAS
Publication of FR2125435A1 publication Critical patent/FR2125435A1/fr
Application granted granted Critical
Publication of FR2125435B1 publication Critical patent/FR2125435B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7204789A 1971-02-12 1972-02-14 Antiarhythmic organomercuric cpds - esp fluorescein derivs Granted FR2125435A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS109171 1971-02-12

Publications (2)

Publication Number Publication Date
FR2125435A1 true FR2125435A1 (en) 1972-09-29
FR2125435B1 FR2125435B1 (enExample) 1975-10-10

Family

ID=5344368

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7204789A Granted FR2125435A1 (en) 1971-02-12 1972-02-14 Antiarhythmic organomercuric cpds - esp fluorescein derivs

Country Status (1)

Country Link
FR (1) FR2125435A1 (enExample)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1517566A (fr) * 1967-03-03 1968-03-15 Ceskoslovenska Akademie Ved Procédé de préparation de dérivés de la fluorescéine marqués par isotopes radioactifs du mercure
FR1517565A (fr) * 1966-04-06 1968-03-15 Ceskoslovenska Akademie Ved Procédé de préparation de dérivés de la fluorescéine marqués par isotopes radioactifs du mercure

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1517565A (fr) * 1966-04-06 1968-03-15 Ceskoslovenska Akademie Ved Procédé de préparation de dérivés de la fluorescéine marqués par isotopes radioactifs du mercure
FR1517566A (fr) * 1967-03-03 1968-03-15 Ceskoslovenska Akademie Ved Procédé de préparation de dérivés de la fluorescéine marqués par isotopes radioactifs du mercure

Also Published As

Publication number Publication date
FR2125435B1 (enExample) 1975-10-10

Similar Documents

Publication Publication Date Title
Schlamowitz An analysis of the time relationships within the cardiac cycle in electrocardiograms of normal men. The duration of the QT interval and its relationship to the cycle length (RR interval)
BR7202331D0 (pt) Conjunto de eletrodo implantavel no tecido do corpo
SE7507851L (sv) Elektrisk hjertstimuleringsanordning.
IL48784A0 (en) Novel substituted perhaloalkylamidines,their preparation and use as cardiac stimulants
IL39391A0 (en) Imidazolidinone-(2)derivatives,their preparation and their use as herbicides
ZA72423B (en) Improvements in or relating to the treatment of diseases of the skin or mucosa
IL39329A0 (en) 2,4,6-triiodo-phenyl derivatives,their preparation and their use as x-ray contrast agents
FR2125435A1 (en) Antiarhythmic organomercuric cpds - esp fluorescein derivs
IT1044867B (it) Apparecchio per produrre correnti d interferenza e correnti di battimento in particolare per l elettroterapia del corpo umano
IT1051609B (it) Originali isopropil 2 tetraidro ossazine 1.3 sostituite,loro procedimento di preparazione e loro applicazione in terapia
IT1048924B (it) Procedimento per la preparazione del 3 idrossil 2 alchil 4 pirone
AU452550B2 (en) The use of diphenylsulfones inthe treatment of mareks disease
FR2330400A1 (fr) Derives d'acides pyrimidine-7-carboxyliques substitues, leur preparation et leurs utilisations therapeutiques
SE396452B (sv) Anordning for indrivning av nitar i rullkroppshallare
SU843970A1 (ru) Ларинготом
IT965949B (it) Attrezzatura per un gioco atto a sviluppare in modo equilibrato i muscoli del corpo
SU531882A1 (ru) Способ подготовки шихты дл получени марганцевых сплавов
USD226709S (en) Fishing plug
CH526297A (de) Vorrichtung zum Diagnostizieren des Herzzustandes eines Patienten
USD231090S (en) Ski-board
NL176838C (nl) Implanteerbare hartstimulator.
SU420050A1 (enExample)
SU510245A1 (ru) Способ лечени фазно-протекающих психозов
USD229673S (en) Lead box
IT1051602B (it) Ossazin,5,6,e,indoli sostituiti,loro procedimento di preparazione e loro applicazione in terapia

Legal Events

Date Code Title Description
ST Notification of lapse